The Incidence of Osteoporosis in Hepatocellular Carcinoma Patients Under 65: A Retrospective Cohort Study

65岁以下肝细胞癌患者骨质疏松症发生率:一项回顾性队列研究

阅读:3

Abstract

INTRODUCTION: Hepatocellular carcinoma (HCC) patients have a heightened prevalence of low bone mineral density (BMD) and the development of osteoporosis. Osteoporosis screening guidelines only recommend dual-energy X-ray absorptiometry (DEXA) scans for females 65 and older and males 70 and older. We set out to analyze the incidence of low BMD in HCC patients under 65 years old and encourage implementation of DEXA screenings for this patient population. METHOD: In this retrospective cohort study, 170 patients under 65 with an HCC diagnosis were analyzed. Hounsfield units (HU) from L1 non-contrast CT scans are a reliable predictor of T-scores from DEXA scans and were used to predict BMD in patients, with scores of less than 165 HU indicative of osteopenia and less than 98 indicative of osteoporosis. RESULTS: The median HU score of patients was 137.2, and the mean score was 142.6 (minimum: 55.4; maximum: 303.1). Of the total 170 patients, 128 (75%) had an HU score of less than 165, indicating a high likelihood of suffering from low BMD. Among low BMD patients, 25 (20%) were identified as within a range of osteoporosis. CONCLUSIONS: HCC patients under 65 have an increased incidence of bone demineralization. We suggest that BMD in HCC patients is an important prognostic tool and parameter to document, as studies have shown that HCC patients with high BMD have longer overall survival than patients with low BMD. Future prospective studies using DEXA scans to assess BMD should be completed to verify the risk of osteoporosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。